ARC Future Fellow to target early cancer detection

By Hudson Institute communications

The Australian Research Council has awarded leading scientist and biological engineer, Dr Michael Gantier, a 2014 Future Fellowship for his outstanding research at the MIMR-PHI Institute.

Dr Michael Gantier targeting early cancer detection.
Dr Michael Gantier

One of 36 biological scientists recognised in the recent round of ARC funding announced by the Minister for Education, the Honourable Christopher Pyne, MP, Dr Gantier received the award for his ongoing research investigating MicroRNAs, which control the use of genetic information to produce proteins. Changes to MicroRNA levels in the cells are associated with development of diseases such as cancers.

In this research, Dr Gantier is hoping to determine the stability of MicroRNAs within human cells and establish their usefulness as biomarkers for early diagnostic testing.

Contact us

Hudson Institute communications
t: + 61 3 8572 2697

About Hudson Institute

Hudson Institute’ s research programs deliver in five areas of medical need – inflammation, cancer, reproductive health, newborn health, and hormones and health. More

Hudson News

Get the inside view on discoveries and patient stories

“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”

Alana Chantry